Cargando…

Locoregional therapy patterns and healthcare economic burden of patients with hepatocellular carcinoma in the USA

AIM: To examine the locoregional therapy (LRT) patterns and the healthcare economic burden of patients with hepatocellular carcinoma (HCC) in the USA. PATIENTS & METHODS: Patients with newly diagnosed HCC were identified from the MarketScan(®) databases (1 July 2015–31 May 2018). The LRTs receiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aly, Abdalla, Lingohr-Smith, Melissa, Lin, Jay, Seal, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369525/ https://www.ncbi.nlm.nih.gov/pubmed/34408847 http://dx.doi.org/10.2217/hep-2021-0001

Ejemplares similares

Epidemiologic, humanistic and economic burden of hepatocellular carcinoma in the USA: a systematic literature review
por: Aly, Abdalla, et al.
Publicado: (2020)

Healthcare costs related to adverse events in hepatocellular carcinoma treatment: A retrospective observational claims study
por: Lal, Lincy S., et al.
Publicado: (2021)

Real-world Treatment Patterns and Reasons for Therapy Selection in Patients with Advanced Hepatocellular Carcinoma in US Oncology Practices
por: Klink, Andrew J, et al.
Publicado: (2022)

Clinical Characteristics, Treatment Patterns, and Healthcare Costs and Utilization for Hepatocellular Carcinoma (HCC) Patients Treated at a Large Referral Center in Washington State 2007–2018
por: Shankaran, Veena, et al.
Publicado: (2021)

Salvage locoregional therapies for recurrent hepatocellular carcinoma
por: Criss, Cody R, et al.
Publicado: (2023)

Recent Advances in Locoregional Therapy of Hepatocellular Carcinoma
por: Podlasek, Anna, et al.
Publicado: (2023)

Economic Burden and Healthcare Resource Use of Alopecia Areata in an Insured Population in the USA
por: Mostaghimi, Arash, et al.
Publicado: (2022)

Treatment Patterns and Economic Burden in Patients Treated for Acromegaly in the USA
por: Chuang, Chien-Chia, et al.
Publicado: (2015)

MRI assessment of hepatocellular carcinoma after locoregional therapy
por: Hussein, Rasha S., et al.
Publicado: (2019)

Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons
por: Makary, Mina S, et al.
Publicado: (2021)

Locoregional therapies for the treatment of locally advanced hepatocellular carcinoma
por: da Motta-Leal-Filho, Joaquim Maurício
Publicado: (2021)

Economic Burden of Treatment‐Resistant Depression Among Patients Hospitalized for Major Depressive Disorder in the United States
por: Lin, Jay, et al.
Publicado: (2019)

Locoregional Therapies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Zane, Kylie E., et al.
Publicado: (2021)

Advances in locoregional therapy for hepatocellular carcinoma combined with immunotherapy and targeted therapy
por: Xue, Jian, et al.
Publicado: (2021)

Combination Therapy of Immune Checkpoint Inhibitors with Locoregional Therapy for Hepatocellular Carcinoma
por: Tamai, Yasuyuki, et al.
Publicado: (2023)

Economic Burden of Comorbidities in Patients with Psoriasis in the USA
por: Wu, Jashin J., et al.
Publicado: (2022)

Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies
por: Makary, Mina S., et al.
Publicado: (2020)

Management of hepatocellular carcinoma from diagnosis in routine clinical practice
por: Lokhandwala, Tasneem, et al.
Publicado: (2023)

Clinical outcomes by Child-Pugh Class in patients with advanced hepatocellular carcinoma in a community oncology setting
por: Aly, Abdalla, et al.
Publicado: (2023)

Influence of the duration of hospital length of stay on frequency of prophylaxis and risk for venous thromboembolism among patients hospitalized for acute medical illnesses in the USA
por: Amin, Alpesh, et al.
Publicado: (2019)

Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions
por: Inchingolo, Riccardo, et al.
Publicado: (2019)

Postsurgical treatment landscape and economic burden of locoregional and distant recurrence in patients with operable nonmetastatic melanoma
por: Tarhini, Ahmad, et al.
Publicado: (2018)

Pretransplant Locoregional Therapy for Hepatocellular Carcinoma: Evaluation of Explant Pathology and Overall Survival
por: Beal, Eliza W., et al.
Publicado: (2016)

Locoregional therapy in hepatocellular carcinoma: when to start and when to stop and when to revisit
por: Lee, J.J.X., et al.
Publicado: (2021)

Combined locoregional and systemic therapy for advanced hepatocellular carcinoma: finally, the future is obscure
por: Farsad, Khashayar, et al.
Publicado: (2020)

Incremental Health Care Burden of Bleeding Among Patients with Venous Thromboembolism in the United States
por: Amin, Alpesh, et al.
Publicado: (2015)

Non-Surgical Locoregional Therapies Alone or in Combination with Systemic Therapy in Patients with Hepatocellular Carcinoma
por: Chami, Perla, et al.
Publicado: (2023)

Incremental Health Care Resource Utilization and Economic Burden of Venous Thromboembolism Recurrence from a U.S. Payer Perspective
por: Lin, J., et al.
Publicado: (2014)

Treatment Patterns and Economic Burden by Lines of Therapy Among Patients with Advanced Hepatocellular Carcinoma Treated with Systemic Cancer Therapy
por: Bonafede, Machaon M., et al.
Publicado: (2019)

The Synergistic Effect of Interventional Locoregional Treatments and Immunotherapy for the Treatment of Hepatocellular Carcinoma
por: Brandi, Nicolò, et al.
Publicado: (2023)

Anti-Glycolytic Drugs in the Treatment of Hepatocellular Carcinoma: Systemic and Locoregional Options
por: Pourbaghi, Miles, et al.
Publicado: (2023)

Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies
por: Yutani, Shigeru, et al.
Publicado: (2017)

Histology of Hepatocellular Carcinoma: Association with Clinical Features, Radiological Findings, and Locoregional Therapy Outcomes
por: Park, Benjamin V., et al.
Publicado: (2019)

The Immune Modulation Effect of Locoregional Therapies and Its Potential Synergy with Immunotherapy in Hepatocellular Carcinoma
por: Singh, Prabhsimranjot, et al.
Publicado: (2020)

Locoregional Combined With Systemic Therapies for Advanced Hepatocellular Carcinoma: An Inevitable Trend of Rapid Development
por: Li, Xin, et al.
Publicado: (2021)

The clinical and economic burden of chronic obstructive pulmonary disease in the USA
por: Guarascio, Anthony J, et al.
Publicado: (2013)

All Stages of Hepatocellular Carcinoma Patients Benefit from Systemic Therapy Combined with Locoregional Therapy
por: Kudo, Masatoshi
Publicado: (2023)

Update on Locoregional Therapies for Cholangiocellular Carcinoma
por: Morawitz, Janna, et al.
Publicado: (2023)

Real-World Analysis of Treatment Patterns, Healthcare Utilization, Costs, and Mortality Among People with Biliary Tract Cancers in the USA
por: Healey, Marcus J., et al.
Publicado: (2022)

Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain
por: De Castro, Javier, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_88seddu5jm47n9oobvg0ereini